Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 391668-75-0 | MDL No. : | MFCD09878908 |
Formula : | C14H17NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CIZCOLAJWVBFIV-UHFFFAOYSA-N |
M.W : | 247.29 g/mol | Pubchem ID : | 17852149 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.43 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 72.76 |
TPSA : | 46.61 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.27 cm/s |
Log Po/w (iLOGP) : | 2.6 |
Log Po/w (XLOGP3) : | 2.17 |
Log Po/w (WLOGP) : | 2.42 |
Log Po/w (MLOGP) : | 1.86 |
Log Po/w (SILICOS-IT) : | 2.38 |
Consensus Log Po/w : | 2.28 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.72 |
Solubility : | 0.468 mg/ml ; 0.00189 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.78 |
Solubility : | 0.409 mg/ml ; 0.00165 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.14 |
Solubility : | 0.18 mg/ml ; 0.000726 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.38 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With Dess-Martin periodane In dichloromethane at 20℃; for 0.5 h; | The above product (163 mg, 0.654 mmol) was dissolved in 3.2 mL of dry dichloromethane, and Dess-Martin periodinane (290 mg, 0.68 mmol) was added to the solution at room temperature. After the reaction mixture was stirred for 30 min at the same temperature, saturated NaHCO3 aqueous solution was added. The mixture was extracted with ethyl acetate, and the extract was washed with brine, and dried over MgSO4. After filtration, the filtrate was concentrated in vacuo and the residue was purified by silica gel column chromatography (hexane/ethyl acetate = 95/5 to 75/25) to obtain the title compound as a white powder (140 mg, 86percent). |
[ 1257849-25-4 ]
1-Boc-4-(3-Formylphenyl)piperazine
Similarity: 0.86
[ 197638-83-8 ]
1-Boc-4-(4-Formylphenyl)piperazine
Similarity: 0.84
[ 174855-57-3 ]
1-Boc-4-(2-Formylphenyl)piperazine
Similarity: 0.84
[ 176980-36-2 ]
tert-Butyl (3-formylphenyl)carbamate
Similarity: 0.81
[ 123387-53-1 ]
tert-Butyl 3,4-dihydroquinoline-1(2H)-carboxylate
Similarity: 0.91
[ 1243474-66-9 ]
tert-Butyl spiro[indoline-3,4'-piperidine]-1-carboxylate hydrochloride
Similarity: 0.86
[ 1257849-25-4 ]
1-Boc-4-(3-Formylphenyl)piperazine
Similarity: 0.86
[ 129487-92-9 ]
tert-Butyl 5-aminoindoline-1-carboxylate
Similarity: 0.86
[ 1243474-66-9 ]
tert-Butyl spiro[indoline-3,4'-piperidine]-1-carboxylate hydrochloride
Similarity: 0.86
[ 129487-92-9 ]
tert-Butyl 5-aminoindoline-1-carboxylate
Similarity: 0.86
[ 957204-30-7 ]
tert-Butyl 6-hydroxyindoline-1-carboxylate
Similarity: 0.85
[ 205383-87-5 ]
tert-Butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate
Similarity: 0.83
[ 252882-60-3 ]
1'-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4'-piperidine]
Similarity: 0.79